This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Duke University, Uti Limited Partnership. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021-2024
Title: Michael P Walsh: Innovator in Kinase Inhibitors
Introduction
Michael P Walsh is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of kinase inhibitors. With a total of 2 patents, his work has the potential to impact the treatment of various disorders, including cancers.
Latest Patents
Walsh's latest patents focus on kinase inhibitors and related methods of use. The present disclosure is directed to compounds that may selectively inhibit Death Associated Protein Kinases (DAPKs) as well as PIM kinases. These compounds can be utilized in methods of treating various disorders, including cancers. This innovative approach highlights the importance of targeted therapies in modern medicine.
Career Highlights
Throughout his career, Michael P Walsh has worked with prestigious institutions such as Duke University and Uti Limited Partnership. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Walsh has had the opportunity to work alongside esteemed colleagues, including Timothy A J Haystead and David A Carlson. These collaborations have further enriched his research and development efforts in the area of kinase inhibitors.
Conclusion
Michael P Walsh is a prominent figure in the field of biochemistry, with a focus on kinase inhibitors that hold promise for treating various disorders. His innovative work and collaborations continue to advance the understanding and application of targeted therapies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile